ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 3647

$882K Total Retail Price of All Prescriptions

Rank: 318 out of 3647

1,184 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 19,482 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 1,507 1,175 1 4
SIMVASTATIN 1,383 1,144 2 1
OMEPRAZOLE 1,361 972 3 3
METFORMIN HCL 1,166 948 4 6
LOSARTAN POTASSIUM 1,127 905 5 11
AMLODIPINE BESYLATE 1,026 763 6 2
LOVASTATIN 1,013 757 7 21
LEVOTHYROXINE SODIUM 845 641 8 5
GLIMEPIRIDE 785 603 9 45
TRAMADOL HCL 666 424 10 22
CARVEDILOL 649 513 11 20
ZOLPIDEM TARTRATE 510 266 12 14
GABAPENTIN 499 302 13 17
HYDROCHLOROTHIAZIDE 475 301 14 9
METOPROLOL TARTRATE 450 350 15 7
FUROSEMIDE 397 300 16 8
WARFARIN SODIUM 396 357 17 15
ALENDRONATE SODIUM 390 344 18 23
ATENOLOL 371 252 19 10
FLUTICASONE PROPIONATE 341 218 20 32
RANITIDINE HCL 325 210 21 29
GLIPIZIDE 276 245 22 41
CLONIDINE HCL 256 161 23 46
METOPROLOL SUCCINATE 251 185 24 18
LANTUS 249 187 25 59
LOSARTAN-HYDROCHLOROTHIAZIDE 241 187 26 48
AMLODIPINE BESYLATE-BENAZEPRIL 223 161 27 74
CLOTRIMAZOLE-BETAMETHASONE 218 142 28 84
ENALAPRIL MALEATE 200 126 29 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 193 124 30 36
TRIAMTERENE-HCTZ 175 132 31 58
HYDRALAZINE HCL 175 123 31 81
ALLOPURINOL 167 144 33 37
CLOPIDOGREL 165 122 34 26
DOXAZOSIN MESYLATE 160 136 35 57
INSULIN SYRINGE 160 110 35 76
BENAZEPRIL HCL 156 119 37 71
GLYBURIDE 152 134 R 38 54
OXYBUTYNIN CHLORIDE 148 123 39 107
AZITHROMYCIN 139 98 40 34
PLAVIX 135 103 41 39
DONEPEZIL HCL 134 101 42 30
PRAVASTATIN SODIUM 127 81 43 16
CYCLOBENZAPRINE HCL 125 47 R 44 98
SERTRALINE HCL 124 84 45 27
TAMSULOSIN HCL 124 102 45 28
HUMULIN 70-30 121 82 47 192
CICLOPIROX 119 76 48 176
ISOSORBIDE MONONITRATE ER 115 98 49 56
MECLIZINE HCL 109 85 50 85
PAROXETINE HCL 104 58 51 60
GEMFIBROZIL 101 24 52 82
DIOVAN 99 90 53 40
BETAMETHASONE DIPROPIONATE 87 50 54 311
HYDROXYZINE PAMOATE 83 49 R 55 416
VENTOLIN HFA 83 61 55 88
BUSPIRONE HCL 81 44 57 162
ACTOS 81 72 57 148
PANTOPRAZOLE SODIUM 79 36 59 38
SPIRONOLACTONE 78 58 60 77
DIOVAN HCT 76 66 61 80
GLIPIZIDE ER 74 55 62 112
ATORVASTATIN CALCIUM 71 60 63 13
TRAZODONE HCL 70 13 64 64
FINASTERIDE 68 67 65 66
LANTUS SOLOSTAR 67 28 66 124
CITALOPRAM HBR 67 35 66 25
GLYBURIDE-METFORMIN HCL 64 50 R 68 94
MELOXICAM 64 49 68 33
TEMAZEPAM 64 41 68 47
SYNTHROID 63 28 71 42
DIGOXIN 63 57 71 51
TORSEMIDE 62 47 73 215
METFORMIN HCL ER 61 45 74 92
ADVAIR DISKUS 60 35 75 52
DILTIAZEM 24HR ER 59 43 76 164
VERAPAMIL ER 58 44 77 99
EXELON 57 47 78 129
NOVOLIN R 55 29 79 139
LEVETIRACETAM 54 28 80 122
TERAZOSIN HCL 54 49 80 103
NAMENDA 54 47 80 49
AMOXICILLIN 53 26 83 133
FAMOTIDINE 53 52 83 61
NITROSTAT 52 19 85 206
IBUPROFEN 52 15 85 55
PHENYTOIN SODIUM EXTENDED 51 0 87 199
PREDNISONE 50 40 88 43
AMITRIPTYLINE HCL 50 22 R 88 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.